CareDx (CDNA) closed the last trading session at $17.81, gaining 24.7% over the past four weeks, but there could be plenty of ...

The upcoming report from CareDx (CDNA) is expected to reveal quarterly loss of $0.19 per share, indicating a decline of 72.7% compared to the year-ago period. Analysts forecast revenues of $63.63 ...

CareDx (CDNA) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- ...

CareDx is estimated to be 35% overvalued based on current share price of US$14.35 Our fair value estimate is 51% lower than CareDx's analyst price target of US$21.83 Today we'll do a simple run ...

CareDx, Inc. (NASDAQ:CDNA) faces fresh uncertainty as proposed reimbursement changes threaten its core testing business, clouding near-term growth even as the company’s expanding transplant solutions ...

Craig-Hallum analyst Alexander Nowak maintained a Hold rating on CareDx (CDNA – Research Report) today. The company’s shares closed yesterday at $9.64. Nowak covers the Healthcare sector, focusing on ...

H.C. Wainwright analyst Yi Chen reiterated a Hold rating on CareDx (CDNA – Research Report) today. The company’s shares closed yesterday at $22.93. Chen covers the Healthcare sector, focusing on ...

CareDx (CDNA) has flipped to profitability for the first time, with net profit margins turning positive and earnings now forecast to soar 80.2% per year. This growth rate far outpaces the company’s ...

AMD outlined its next steps in the AI and HPC accelerator market at its 2025 Financial Analyst Day, revealing the Instinct MI400 series based on the CDNA 5 architecture.

AMD's new Instinct MI325X AI accelerator will use the same CDNA 3 architecture as the just-launched Instinct MI300 series AI accelerators, with a monster 288GB of HBM3E memory with up to 6TB/sec of ...